Myths About GLP-1 and Weight Loss

In this episode, Rick and Greg discuss a groundbreaking 2026 policy statement from leading obesity organizations that redefines how obesity should be treated in modern medicine.The key takeaway: Obesity is a chronic, biologically driven disease—and it’s being significantly underdiagnosed and undertreated.  The new guidelines emphasize:Earlier and more aggressive interventionCombining lifestyle changes with medication, not delaying treatmentStrong evidence supporting the safety and effectiveness of long-term obesity medicationsA shift away from focusing solely on weight toward broader health outcomes like cardiovascular risk, diabetes prevention, and overall quality of lifeRick and Greg also highlight a critical reality: stopping treatment often leads to weight regain, reinforcing the need to view obesity like other chronic diseases that require ongoing management.This episode underscores a major shift in healthcare—from treating complications to addressing obesity at its root, earlier and more effectively.